Zebrafish model reveals how BCG vaccine triggers immune response in bladder cancer

Using zebrafish “Avatars”, an animal model developed by the Cancer Development and Innate Immune Evasion lab at the Champalimaud Foundation (CF), led by Rita Fior, Mayra Martínez-López – a former PhD student at the lab now working at the Universidad de las Américas in Quito, Ecuador – and colleagues studied the initial steps of the Bacillus Calmette-Guérin (BCG) vaccine’s action on bladder cancer cells.

Video-Based Antenatal Care Education Helped Parents of Preemies

Pregnant patients who received educational video content via text messages about antenatal care for babies born preterm were more prepared for maternal and infant health

August 1, 2023

COVID-19 vaccination before first infection may reduce risk of developing long COVID

Receiving at least one dose of a covid-19 vaccine before the first infection is strongly associated with a reduced risk of developing post-covid-19 condition, commonly

November 23, 2023

Pα+ Psychedelic Bulletin #167: Lykos Insiders, Affiliates Respond to Critics; FDA-Affiliated Workshop Discusses Ketamine; EMA Associates Publish Recap of Psychedelics Workshop – Psychedelic Alpha

In this Issue Lykos Insiders, Affiliates, Respond to Critics Might FDA Miss Its August 11th Goal Date? FDA-Affiliated Workshop Discusses Ketamine’s Use In Mental Health

July 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.